The exterior of NeoGenomics’ headquarters in Fort Myers. The company provides oncology diagnostic and precision medicine testing services.
Fort Myers-based NeoGenomics has expanded its partnership with Indica Labs to develop its artificial intelligence-powered digital pathology capabilities and improve cancer diagnostics. The company will use Indica Labs' cloud-based HALO AP platform to manage digital pathology images and integrate AI tools across its operations. The technology is designed to streamline laboratory workflows, reduce integration costs and support faster analysis of cancer tissue samples. The expansion also positions NeoGenomics to pursue AI-based biomarker testing, clinical trial collaborations and diagnostic development. The companies have worked together since 2015. HALO AP is not cleared by the Food and Drug Administration for clinical diagnostic use in the United States.Â
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.